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With the development and widespread investigative use of monoclonal anti- 
bodies (MAb), ~ it has been possible to characterize and define a number of cell 
surface differentiation antigens that play critical roles both in the regulation of 
the immune response and in the process of intercellular communication. Specif- 
ically, MAb that define characteristic T  cell antigens and T  cell  subsets  have 
been described in human (1,  2) and murine (3) systems. Functional studies have 
demonstrated that many of these cell surface antigens which previously served 
only as markers are  involved in specific immune functions. For example, the 
human pan-T cell antigen, T3, defined by MAb OKT3, Leu-4, and UCHT-1, 
has been shown to play a  critical role in the T  cell antigen recognition process 
(4) and may exist as a complex on the T  cell surface with the antigen-specific T 
cell receptor (5). In addition, Lyt-2 and OKT8/Leu-2 have been postulated to 
act as auxiliary recognition structures for class  I-restricted T  cells  in mice and 
humans (6-8);  L3T4 and OKT4/Leu-3 antigens are thought to function in a 
similar manner for class II-restricted T  cells (7-9). These molecules are thought 
to  increase  the  affinity of the  antigen-specific T  cell  receptor  for  its  target 
antigen. 
We have attempted to further elucidate roles for cell surface antigen involve- 
ment in T  cell activation by producing MAb to T  cell hybridomas and screening 
these MAb for their ability to modulate (stimulate or inhibit) T  cell functions. 
This report  describes the  production and initial characterization of one  such 
stimulatory rat monoclonal antibody, G7, that recognizes the murine pan T  cell 
antigen, Thy-1.  G7  is  a  potent mitogen for resting T  cells,  and also  induces 
interleukin 2 (IL-2) secretion from normal T  cells and T  cell hybridomas. The 
possible  relationship  of Thy-1  to  the  T3  molecular  complex  on  human  T 
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lymphocytes is discussed. 
Materials and Methods 
Experimental Animals.  Outbred Swiss mice, outbred nu/nu mice, BALB/c mice, AKR 
mice, and Lewis rats were obtained from the Animal Production Unit, National Institutes 
of Health. 
Media and Culture Conditions.  Dulbecco's modified Eagle's medium (DMEM) with 4.5 
g  glucose/liter (M.  A.  Bioproducts, Walkersville, MD) supplemented with nonessential 
amino acids (0.1  mM), sodium pyruvate (1  mM), glutamine (300/~g/ml), penicillin (100 
U/ml), streptomycin (100 ~g/ml),  5-fluorocytosine (1  gg/ml),  2-mercaptoethanoi (5  x 
10  -5 M), and  10-20% fetal calf serum (FCS) (KC Biologicals,  Lenexa, KS) was used for 
all cell cultures. 
Cell Lines.  The properties of the  murine B cell lymphoma M12.4.1,  an  Ia-bearing 
tumor (10) and the interleukin 2 (IL-2)-dependent HT-2 cells (11) have previously been 
described. The nonsecretor bybridoma cell line, SP2/O-Ag-14 (SP2/O), was used for all B 
cell fusions. BW 5147, a murine AKR thymoma line was used for all T  cell fusions. 
Monoclonal Antibodies.  The following culture supernatant fluids containing rat MAb to 
murine  lymphocyte surface antigens  were  used  in  this  study:  53.7.3  (anti-Lyt-1) was 
derived by Ledbetter and Herzenberg (3);  15E (anti-Thy-l.2), derived by Sarmiento et 
al.  (12) and Jlj (anti-Thy-l.2), derived by Bruce et al.  (13) were obtained from Dr. M. 
Norcross, NIH.  A  purified rat  MAb to  murine  Thy-l.2, 30-H12,  was  obtained from 
Becton, Dickinson & Co.,  Sunnyvale, CA.  A  mouse MAb to Thy-l.2 was obtained in 
ascites form from New England Nuclear, Boston, MA. This reagent was used to deplete 
T  cells from spleen cell populations. A rat MAb to the murine IL-2 receptor, 7D4, has 
been previously described (14). The MAR  18.5 monoclonal antibody to rat kappa chain 
was produced by Lanier et al. (15). 
IL-2 Production Assay.  Assays of IL-2-driven proliferation were performed by measur- 
ing [SH]thymidine ([3H]TdR) incorporation of 5 ×  10  s HT-2 cells in triplicate stimulated 
by a  33% dilution of IL-2-containing supernatant fluids at 37°C for 28 h  in complete 
medium.  [3H]TdR was  added  to  the  culture  for the  final  4  h.  The amount of IL-2 
measured in this assay in these experiments was always limiting (less than maximal IL-2- 
driven proliferation using concanavalin A (Con A)-stimulated rat spleen cell supernatants). 
The SEM was always <20% of the mean in all proliferation assays, and for simplicity, only 
the mean is reported. 
Production and Characterization of T Cell Hybridomas.  Autoreactive T  cell hybridomas 
were  made  in  the  course of antigen-specific T  hybridoma  production, as  previously 
described (16).  Briefly, BALB/c mice were immunized in the footpads with pork insulin 
emulsified in complete Freund's adjuvant (CFA);  7 d  later, draining lymph nodes were 
removed and restimulated with pork insulin and syngeneic antigen-presenting cells (APC) 
in vitro for 72 h. Recovered blasts were fused to BW 5147 cells in supplemented DMEM 
containing hypoxanthine, aminopterin, thymidine, and 20% fetal calf serum (FCS). After 
7-10 d, growing hybrids were expanded and tested for IL-2 production when challenged 
with antigen and syngeneic APC.  Positive hybrids were cloned at least once at limiting 
dilution and frozen in large quantities. 
The hybridomas C6/G8 and F7/G3 were produced in the same fusion, from a BALB/c 
mouse immunized to pork insulin. Both were found to produce IL-2 when challenged 
with the syngeneic APC M12.4.1  in the presence or absence of the immunogen, pork 
insulin. 
Production ofMAb G7.  A single Lewis rat was immunized intraperitoneally with 40 × 
106  C6/G8  T  hybridoma  cells  emulsified  in  CFA.  3  wk  later  the  rat  was  boosted 
intraperitoneally with an additional 40 x  106 T  hybridoma cells. After an additional 3 
wk, the rat was boosted with 40 x  108 C6/G8 cells i.v. and i.p. Three days later the spleen 
was removed and cells fused to SP2/0 by established methods (17).  Supernatants from 
341 wells containing growing hybridomas were screened for their ability to either augment 
or inhibit IL-2 secretion by the T  hybrid C6/G8 (1 ×  105 cells per microtiter well) in the 
presence of irradiated M 12.4.1 stimulator cells (1 ×  104 cells per microtiter well). Three 718  ANTI-THY-I-INDUCED T  CELL  ACTIVATION 
supernatants  were  detected,  which  on  initial  screening  augmented  T  hybridoma  IL-2 
production, but only one of these (G7) maintained this property after cloning at limiting 
dilution. G7 ascites was produced by injecting 5 ×  106 hybridoma cells into outbred nu/ 
n u mice that had been previously primed with pristane (Aldrich Chemical Co., Milwaukee, 
WI). G7 was purified by affinity chromatography on a Sepharose-Protein A column. The 
monoclonal antibody was determined to be of IgG2c class by Ouchterlony analysis with 
class-specific typing antisera (Miles Laboratories, Elkhart, IN). 
Cell Purification and Proliferation Assays.  Splenic T  cell-enriched cells were prepared by 
passage over nylon  wool  columns.  For proliferation assays,  T  cell-enriched  cells  were 
resuspended  in  medium  containing  2.5%  human  serum  and  distributed  into  96-well 
microtiter plates at 4 ×  105/well (Costar, Cambridge, MA) with the indicated concentration 
of MAb in 200 gi of media for 4 d unless otherwise specified. The cells were pulsed with 
[3H]TdR for the  final  18  h  of culture.  T  cell-depleted  spleen  cells were prepared by 
treating  cell  suspensions  with  anti-Thy-l.2  in  the  presence  of guinea  pig  serum  as  a 
complement source. 
Fluorescent Staining.  The  cell  population  (2  ×  106) selected  for  analysis  was  first 
incubated with an excess of G7 culture supernatant fluid for 30 min at 4°C, and then 
washed three times with Hank's balanced salts solution (Biofluids, Inc., Rockville, MD) 
containing  0.1%  NaN~ and  3%  FCS.  These cells were then  stained  with  an excess of 
fluorescein isothiocyanate (FITC) (Calbiochem-Behring Corp.,  La Jolla, CA)-conjugated 
monoclonal mouse anti-rat kappa chain  antibody (MAR  18.5) and  then analyzed on a 
fluorescence-activated cell sorter, FACS II (B-D FACS Systems, Becton, Dickinson & Co., 
Mountain  View, CA).  For analysis of IL-2 receptor expression, splenic T  cell-enriched 
cells  were  cultured  at  2  ×  10b/ml  with  either  Con  A  (5  #g/ml) or G7  (1:500  ascites 
dilution) monoclonal antibody. After 72 h of culture, a monoclonal antibody to the murine 
1L-2 receptor, 7D4, which had been conjugated to FITC, was added in excess to 2 ×  106 
of G7-stimulated, Con A-stimulated, or unstimulated T-enriched spleen cells. 
Ceil Surface Labeling,  lmmunoprecipitation,  and Sodium  Dodecyl Sulfate Polyacrylamide Gel 
400-600  ×  10  BALB/c thymocytes from 3-6-wk-old mice  Electrophoresis (SDS-PAGE).  6 
or 40-80  ×  106 C6/G8 T  hybridoma cells were labeled with NaI2SI (Amersham Corp., 
Arlington  Heights,  IL) by lactoperoxidase (Worthington  Biochemical Corp.,  Freehold, 
NJ)-catalyzed cell surface iodination without carrier K127I (18). Labeled membrane pro- 
teins were then extracted with 0.5 % 3-[(3-cholamidopropyl)dimethylammonio]-  l-propane- 
sulfonate (CHAPS), in a 0.05 M Tris, 0.005 M EDTA, and 0.03 M NaCI (pH 7.4) buffer 
containing 1 mM phenylmethylsulfonyl fluoride, 50/~g/ml soybean trypsin inhibitor, and 
50 #g/ml aprotinin. 
The detergent extracts were precleared by serial incubation with Sepharose 4B, first 
coupled with  mouse  IgG, then  coupled with either protein  A-rabbit anti-rat  Ig (Miles 
Laboratories) or  MAR  18.5  for 30  min at 4°C.  To couple antibodies to a  solid-phase 
reactant, purified G7 was reacted with protein A-Sepharose; purified 30-H 12 was reacted 
with  rabbit anti-rat  Ig-protein A-Sepharose;  and  culture  supernatants  from  15E  were 
incubated  with  MAR  18.5-Sepharose  for  45  min  at  25°C.  These  antibody-coupled 
Sepharose beads were then washed and reacted with the previously precleared extract for 
60  rain at 4°C  with continuous agitation.  Immunoprecipitates were then washed three 
times through the same buffer used for membrane protein solubilization, which contained 
0.2% CHAPS, 0.2% deoxycholate, and 30% glycerol. The precipitated samples were then 
boiled for 5 rain in buffer containing 5% SDS and 0.1  M dithiothreitol and then subjected 
to SDS-PAGE containing 0.2% SDS in 12.5% acrylamide slab gels (19).  After electropho- 
resis, the gel was fixed in 20% trichloroacetic acid, stained with Coomassie blue, destained, 
and dried, and autoradiographs were produced using a Kodak X-Omatic intensifier screen 
at -70°C for 1-7 d. 
Results 
Induction  of IL-2  Secretion  by MAb  G7.  To  produce  xenogenic  monoclonal 
antibodies to an autoreactive T  cell hybridoma, a  single rat was immunized with GUNTER,  MALEK,  AND  SHEVACH  719 
the autoreactive T  cell hybridoma, C6/G8.  After fusion to the murine SP2/0 
line,  the resulting supernatants  were screened for their ability to augment or 
suppress IL-2 production by the C6/G8  T  hybridoma induced in the presence 
of the  syngeneic B  lymphoma, M12.4.1.  After limiting dilution  cloning,  one 
MAb, G7,  was found to be able to induce IL-2  secretion from C6/G8  in  the 
presence or absence of stimulator cells (Fig.  1). However, the stimulating prop- 
erties of G7 were not specific for the immunizing hybridoma as another T  cell 
hybridoma (F7/G3) had an identical dose response curve (Fig. 1). In fact, G7 has 
been shown to induce IL-2 secretion from any T  cell hybridoma tested that is 
known to be capable of IL-2 secretion as judged by its response to specific antigen 
plus APC, or Con A (data not shown). Also it should be noted that G7 did not 
stimulate HT-2  cell thymidine incorporation in  multiple determinations (data 
not shown). 
G7 was also able to induce IL-2 production from nylon column-purified splenic 
T  lymphocytes (Fig.  2).  As in  the case of the T  cell hybridomas, there was a 
concentration-dependent production of IL-2.  The proliferation of HT-2  cells 
was generally lower when supernatants from G7-activated spleen T  cells were 
assayed than when T  hybridomas were activated by G7.  One likely explanation 
for this finding is that the growth of T  cell hybridomas is IL-2 independent while 
activated spleen cells both produce and consume IL°2.  The T  cell hybridoma 
supernatants allow a measurement of total IL-2 produced, while the spleen cell 
supernatants only indicate excess unbound IL-2 in the culture at a given point 
in time. 
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FIGURE  1.  G7-induced IL-2 secretion  from T cell hybridomas.  Dilutions of G7 cell culture 
supernatant were added to 1 x  l0  s (C6/G8 (0) or F7/G3 (O) T  hybridomas.  Supernatants 
were removed after 48 h and added in 33% final concentration to HT-2 cells. Proliferation 
was measured by [aH]TdR incorporation. 720  ANTI-THY-I-INDUCED  T  CELL  ACTIVATION 
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FIGURE 2.  G7-induced  IL-2  secretion  from  T  cell-enriched spleen  cells.  T  cell-enriched 
spleen cells (4  X  10  ~) were treated with varying concentrations of G7 (0) or SP2/0 (O) cell 
culture supernatant. Supernatants were removed after 24 h  and added in 33% final concen- 
tration to HT-2 cells. Proliferation was measured by [~H]TdR incorporation. 
Induction oft Cell Proliferation and IL-2 Receptor Expression by MAb G7.  When 
T cell-enriched spleen cells were cultured for 4 d with varying concentrations of 
protein  A-purified  G7,  a  vigorous  proliferative  response  was  observed  that 
plateaued at an antibody concentration of 25-50 #g/ml (Fig. 3). Kinetic studies 
revealed that  this response peaked at  4  d  of culture (Fig.  4).  In  general, the 
proliferative response to G7 was equal or greater than that observed with optimal 
concentrations of Con A or phytohemagglutinin (results not shown). 
It has been shown (20, 21) that resting T  cells cannot respond to IL-2 unless 
they first express IL-2 receptors. Thus, although G7  stimulated IL-2 secretion 
from resting T  cells, this mechanism alone should not account for the prolifera- 
tion of resting T  cells. To test the hypothesis that G7 was also able to stimulate 
IL-2 receptor expression,  T  cell-enriched splenocytes were incubated with an 
optimal dilution of the G7 MAb or Con A  for 72 h. After this time period the 
cultures were harvested, washed, and stained with an FITC-conjugated anti-IL- 
2 receptor antibody, 7D4. As a control, unstimulated T  cell-enriched spleen cells 
were  first  incubated  with  G7  at  4°C,  then  stained  with  FITC-7D4.  T  cells 
activated by G7 were strongly positive for the IL-2 receptor while unstimulated 
T  cells showed little reactivity with FITC-7D4 (Fig. 5).  In this particular study, 
G7-activated T  cells expressed a  higher density of the IL-2 receptor than Con 
A-activated cells (Fig. 5), although in other studies both agents induced a similar 
level of IL-2 receptor expression (data not shown). 
Tissue Distribution  of the  Antigen  Recognized by  G7.  In  addition  to  positive GUNTER,  MALEK,  AND  SHEVACH 
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FIGURE  3.  G7-induced T cell proliferation. T  cell-enriched spleen cells (4 ×  10  ~) were treated 
with varying concentrations of protein A-purified G7 MAb. Proliferation was measured in a 
4-d culture by [SH]TdR incorporation. 
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FIGURE 4.  Kinetics of G7-stimulated T  cell proliferation. G7 in ascites form at 1 : 100 (@) or 
1:500 (O) dilution was added to cultures of 4 x  105 T  cell-enriched spleen cells. Proliferation 
was  measured after the indicated time period by [SH]TdR incorporation. 
reactivity with the immunizing T  cell hybridoma (C6/G8)  (Fig. 6), G7 appeared 
to recognize a pan-T cell antigen.  FACS analysis showed the antigen recognized 
by G7 to be present on all T  cells as well as thymocytes from outbred mice, and 
to be absent from splenic T  cell-depleted populations and bone marrow. G7 also 
reacted with the BW 5147 T  hybrid fusion partner (data not shown). 
Immunoprecipitation Studies.  BALB/c thymocytes or the C6/G8 T  cell hybri- 722  ANTI-THY-I-INDUCED  T  CELL  ACTIVATION 
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FIGURE 5.  The  G7  MAb  stimulates  IL-2  receptor  expression.  Resting,  Con  A-,  or  G7- 
activated T  cell-enriched spleen cells were stained directly with FITC-conjugated 7D4 anti- 
body. 
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FIGURE 6.  Tissue distribution of the antigen recognized by GT.  Cellular populations were 
prepared as described in Materials and Methods. The indicated cells were either stained with 
G7 cell culture supernatant and a  FITC-conjugated mouse anti-rat kappa chain MAb, MAR 
18.5 (  ), or MAR 18.5 alone (- -  -), then analyzed by FACS. 
doma were labeled with 125I by lactoperoxidase-catalyzed iodination, followed by 
lysis  in  CHAPS,  immunoprecipitation, and  SDS-PAGE  (Fig.  7).  In  thymocyte 
lysates, G7 precipitated a  28-32  kD protein and a  less intense 50 kD (referred 
to as p50) protein (Fig. 7D). When extracts from thymocytes were analyzed, the 
lower  28-32  kD  band  appeared  to  be  composed  of multiple  (four)  discrete 
components. When the T  hybridoma lysate was precipitated with G7, the lower 
molecular weight material  appeared as a  single band  (Fig.  7, F  vs.  D).  Under 
nonreducing conditions, the migration distances did not change, indicating that 
the  proteins  recognized  by  G7  were  not  subunits  connected  by  interchain 
disulfide bonds (results not shown). 
Because  of the  presence  of a  very  prominent  band  of ~28  kD  in  the  G7 
immunoprecipitates and because G7 identified a pan-T cell antigen, the possibil- 
ity  existed  that  G7  recognized  at  least,  in  part,  the  Thy-1  antigen.  When 
thymocyte lysates prepared  with CHAPS  were analyzed with  two monoclonal GUNTER,  MALEK,  AND  SHEVACH  723 
FIGURE 7.  Molecules precipitated by the G7 MAb. z2SI-surface-labeled BALB/c thymocytes 
(A-D) or C6]G8 T hybridoma (E-F) were extracted in CHAPS and immunoprecipitated with 
G7 (D, F),  the anti-Thy-l.2  MAb  30-H12 and  15E  (A and  C,  respectively),  or protein  A- 
Sepharose beads alone as controls (B, E). 
FIGURE 8.  The G7 MAb recognizes the Thy-1 antigen. 125I-surface-labeled BALB/c thymo- 
cytes were extracted  in  CHAPS and  first immunoprecipitated with  30-H12 (a),  G7 (b), or 
protein A-Sepharose beads control (c). The supernatant from each of the first immunoprecip- 
itations was split into three equal parts and immunoprecipitated a second time with  30-H12 
(A), G7 (B), or protein A-Sepharose beads (C). 
anti-Thy  1.2  reagents,  30-H12  and  15E,  a  precipitation  pattern  identical  to that 
of G7  was observed  (Fig.  7  A  and  C). To  confirm  that G7  recognized  the Thy-1 
antigen,  a  sequential  immunoprecipitation  study  was  performed  on  CHAPS 
extracts of BALB/c  thymocytes (Fig.  8).  In this study, aliquots  of the lysate were 
first  treated  with  an  excess  of G7,  30-H12,  or protein  A-Sepharose  beads.  The 724  ANTI-THY-I-INDUCED T  CELL  ACTIVATION 
supernatants  from  each  of these  three  precipitates  were  then  subjected  to  a 
second  precipitation  with  G7,  30-H12,  or  protein  A-Sepharose.  Pretreatment 
with  G7  removed  the  bands  reactive  with  30-H12  and  pretreatment  with  30- 
H 12  markedly decreased reactivity with G7  (Fig.  8).  Precipitation  with protein 
A-Sepharose had no effect on subsequent precipitation by either G7 or 30-H 12. 
The band represented by p50 was only faintly present in these experiments and 
it is difficult to state with certainty whether it was precleared by either G7 or 30- 
H12.  The  p50  band  was also present  in  G7  immunoprecipitates performed  in 
other detergents, and was not seen in immunoprecipitation performed with non- 
anti-Thy-1  MAb (data not shown). 
Effects of Other Anti-Thy-1  MAb on  Resting and G7-activated  T  Cells.  Taken to- 
gether the tissue distribution  studies and the  immunoprecipitation  experiments 
strongly suggest that G7 recognizes the Thy-1 antigen and perhaps an additional 
membrane antigen (p50). To determine whether the ability of G7 to activate T 
lymphocytes was a unique property of this antibody, a panel of several monocional 
anti-Thy-1  antibodies was tested on both spleen T  cell-enriched cells for prolif- 
erative effects and on a T  cell hybridoma for IL-2 production (Table I). In these 
TABLE  I 
Comparison of Anti-Thy-1 MAb in T Cell Proliferation and IL-2 
Production Assays 
Antibody*  [SH]TdR Incorporation* 
Exp. 1: T Cell Proliferation 0 
Supernatant dilution 
1:8  1:16  1:32  1:64 
G7  42,300  20,200  7,100  2,100 
30-H12  1,700  900  2,700  1,500 
15E  1,700  1,100  1,000  1,100 
Jlj  2,700  1,600  1,800  1,200 
SP2/0  1,900  900  1,400  900 
Exp. 2:HT-2 Proliferation (T hybrid IL-2 Production) ! 
Supernatant dilution 
1:4  1:8  1:16  1:32 
G7  54,400  66,200  35,900  23,100 
30-H12  300  100  900  1,400 
15E  1,900  1,100  900  300 
Jlj  600  400  300  800 
SP2/0  1,200  1,000  900  300 
* Described in Materials and Methods. 
Mean rounded to nearest hundred. 
a 4 x  105 nylon wool-purified BALB/c spleen cells were incubated with 
the indicated dilution of anti-Thy-1 or SP2/0 control cell culture super- 
natants. After 3 d, the cultures were pulsed with [SH]TdR and harvested 
18 h later. 
! 1 x  105 C6/G8 T  hybridoma  ceils were cultured  with the indicated 
dilution of anti-Thy-1 or SP2/0 control cell culture supernatant.  After 
48 h, supernatant was removed and added to IL-2-dependent HT-2 cells 
as described in Materials and Methods. GUNTER,  MALEK,  AND  SHEVACH  725 
experiments, none of the other anti-Thy-1 monoclonal antibodies showed the T 
cell-activating properties  of G7  at  the  dilutions  tested.  A  mouse  monoclonal 
antibody to the Thy-l.2 allele also had no activating effects (data not shown). In 
addition,  MAb specific for the Thy-l.2 allele were able to block G7-mediated 
proliferation of T  lymphocytes from BALB/c but not AKR mice (Table II). 
Discussion 
The Thy-1 antigen of mice was one of the first differentiation antigens to be 
discovered on thymocytes by Reif and Allen in  1964  (22) as alloantigens later 
designated Thy-l.1 and Thy-l.2. The Thy-1 antigen is coded for by a gene on 
chromosome nine of the mouse (23) and is a  glycoprotein of 25,000-30,000 
daltons found on thymocytes, peripheral T  cells, fibroblasts, epithelial cells, and 
neurons in the mouse (22, 23). This molecule is of interest because it has amino 
acid sequence homology to immunoglobulin (25), implying that Thy-1  may be 
involved in immune recognition function. During the process of screening rat 
monoclonal antibodies to murine autoreactive T  cell hybridomas, we identified 
a single monoclonal antibody to Thy-1, G7, which was a potent inducer of IL-2 
production from all  functioning T  cell hybridomas as well as from normal T 
cells. G7 also was a  potent mitogen for normal T  cells and was as effective as 
Con A in its ability to induce expression of the IL-2 receptor on normal cells. 
No other mitogenic monoclonal antibodies to nonidiotypic determinants on 
murine T  lymphocytes have been identified, including a number of anti-Thy-1 
reagents. However, certain anti-Thy-l.2 MAb were able to block G7-mediated 
T  cell proliferation on Thy-l.2  ÷ cells. This implies that the epitopes recognized 
by these reagents are in close proximity to the G7-binding site.  Alternatively, 
binding of the anti-Thy-1.2 reagents may induce conformational and/or allosteric 
changes in the molecule preventing subsequent binding of G7 irrespective of the 
proximity of epitopes. The failure of certain anti-Thy-1 sera, anti-Thy-1 mono- 
clonal antibodies, or anti-Thy-1 alloantisera to activate T  cells is not secondary 
to a  failure of these antibodies to cross-link Thy-1  molecules, since Jones and 
Janeway (26) have demonstrated that the addition of a second layer of anti-Ig 
antibody sufficient to cap Thy-1 failed to stimulate the T  cells to divide. On the 
TABLE  II 
Effects of T  Celt-Spec~c MAb on G7-Mediated T Cell Proliferation * 
Antibody 
[3H]TdR incorporation* 
AKR  BALB/c 
None  161,100  227,500 
Rat anti-Thy- 1.20  162,900  9,700 
Mouse anti-Thy- 1.21  180,900  1,100 
Rat anti-Lyt-11  199,100  258,100 
* 4 X 10  ~  nylon wool-purified AKR or BALB/c spleen cells were incubated 
with a  1:400 dilution of MAb G7 ascites and the indicated anti-Thy-1.2 
or anti-Lyt-1 antibodies. The cultures were harvested as in Table I. 
* Mean rounded to nearest hundred. 
0 MAb 15E cell culture supernatant at 1:4 dilution. 
! 1:400 dilution of ascites. 
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other hand, although the stimulatory properties of MAb G7 are unique, it has 
been known for several years that rabbit antisera raised against mouse brain that 
show Thy-1 specificity are both mitogenic and able to stimulate IL-2 secretion 
from murine T  cells (26-28).  Serological and biochemical studies by Maino et 
al. (29) strongly suggest that the mitogenic determinant recognized on the surface 
by rabbit anti-mouse brain antiserum is located on the Thy-1 molecule. In the 
rabbit  anti-mouse  brain  model,  T  cell  activation  has  been  shown  to  require 
accessory cells that bear Fc receptors (26, 27). In contrast, G7-mediated induction 
of IL-2 secretion from T  cell hybridomas is performed in the total absence of 
any type of accessory cells. Studies to evaluate the accessory cell requirements of 
G7-induced proliferation of normal T  cells are in progress. 
There are a  number of interesting similarities in  the functional properties, 
tissue distribution, and biochemical characteristics of the antigens identified by 
MAb  G7  and  those  identified  by  monoclonal  reagents,  OKT3,  Leu-4,  and 
UCHT-1,  to  the T3  complex on  human T  lymphocytes. G7  and the anti-T3 
reagents are both  potent  mitogens for resting T  cells and in  this respect are 
unique  among  MAb  reacting with  normal  T  cells.  However,  the  functional 
properties of these reagents exhibit several differences. Although the anti-T3 
reagents at low concentrations induce DNA synthesis, at higher concentrations 
the antibodies block the proliferative responses to soluble protein antigens and 
alloantigens (30) as well as both the generation and effector phases of cytolytic 
T  lymphocyte (CTL) function (4, 30). In contrast, G7 in all concentrations thus 
far tested always stimulates proliferation and preliminary data indicate that G7 
does not inhibit the effector phase of CTL  function (results not shown). One 
other functional characteristic of the T3 complex is that it can be easily modu- 
lated from the cell surface by culture with anti-T3  reagents at  37°C  (31);  G7 
thus far has failed to  modulate its target antigen under a  number of culture 
conditions. 
Although the OKT3 MAb was initially reported to react with all peripheral T 
]ymphocytes and only  10%  of human thymocytes (1),  Leu-4 reacted with  70- 
90%  of human thymocytes (32).  In addition, both Leu-4 and UCHT-1  reacted 
with cerebellar Purkinje's cells of several species (33). Thy-1 is also present on 
most rodent neuronal cells as reported by Campbell eta[. (34).  Although there 
have been several reports of Thy-l-positive human peripheral T  lymphocytes 
(35, 36) and of at least one monoclonal antibody to a human Thy-l-like molecule 
(37), the human Thy-1 homolog is absent from the majority of human thymo- 
cytes. Also,  in  the murine system, a  variant of the Thy-1  molecule has been 
described that is present only on thymocytes, but not peripheral T  lymphocytes 
(38). Although multiple explanations exist to explain these differences in tissue 
distribution,  one interpretation of these data would be that a  basic T3/Thy-1 
complex exists on all T cells in men and mice, but that there are subtle differences 
in carbohydrate or protein structures restricted to various cellular subpopula- 
tions, which may account for the differential reactivity of the various antibodies 
mentioned above. 
The similarity between the T3  antigen(s) and the antigens identified by G7 
also partially extends to the biochemical properties of the antigens. The main 
target of the anti-T3 reagents is thought to be borne by a  20 kD glycoprotein. GUNTER,  MALEK,  AND  SHEVACH  727 
In  addition,  glycoproteins of 25-28,  37,  and  44  kD  were  found  in  anti-T3 
immunoprecipitates from surface-labeled cells (39). G7 immunoprecipitates con- 
sisted of a  28  kD band and a  less prominent 50  kD protein;  several other rat 
monoclonal anti-Thy-1 reagents also identified a p50 component. The pS0 band 
is an attractive candidate for one of the higher molecular weight bands seen by 
the anti-T3  reagents. Although Thy-1  glycoproteins have not been previously 
identified in association with other membrane proteins, the possibility remains 
that  Thy-1  and  p50  exist  as  a  complex  on  the  T  lymphocyte cell  surface. 
Alternatively, the two molecules may share epitopes recognized by a number of 
rat anti-mouse Thy-1 antibodies. We also cannot rule out the possibility that p50 
represents a dimer of the Thy-1 molecule, although such a dimer would have to 
be resistant to the SDS and reducing conditions used in these experiments. 
Recent studies of the T3  antigen on cloned lines of antigen-specific T  cells 
have suggested that the T3 complex is closely associated with the T  cell receptor 
(5, 40). Immunoprecipitation with G7 under a variety of detergent and buffer 
conditions have not revealed coprecipitation of a heterodimer resembling the T 
cell antigen receptor (data not shown). In addition, sequential immunoprecipi- 
tation  studies  using  a  clonotypic monoclonal  antibody  to  the  T  cell  antigen 
receptor produced by Samelson et al. (41) have shown that the p50 band is not 
part  of the T  cell  receptor heterodimer (Samelson and  Gunter,  unpublished 
observations).  It is possible that the noncovalent interactions between putative 
Thy-1/T cell receptor complexes are weaker in the mouse than in man and that 
the molecules dissociate upon detergent solubilization, or that the G7 MAb itself 
may disrupt molecular associations present in the detergent lysate. 
Although considerably more experimental analysis will be required to prove 
the hypothesis that  the  Thy-1  antigen is  part  of a  molecular complex which 
resembles the T3 complex on human cells, the G7  MAb should prove to be a 
very useful reagent for analysis of some of the early events in the T cell activation 
process.  As  G7  can  stimulate  IL-2  production  from a  homogeneous, cloned 
population  of T  hybridoma cells  in  the absence of accessory cells,  it  can  be 
postulated  that  the  interaction  of G7  with  its  antigen  mimics an  antigen- or 
mitogen-binding event necessary for triggering of IL-2 release. It is possible that 
when  G7  binds  to  its  epitope  on  the  hybridoma cell  surface,  it  may induce 
membrane conformational charges and/or initiate membrane ionic fluxes nec- 
essary for IL-2 production. An analysis of the mechanism of G7-induced activa- 
tion of normal cells is somewhat more complicated. G7 does not act directly to 
drive resting T  cells to proliferate since IL-2 receptors are not present on resting 
T  cells  (20,  21).  G7  must  first  induce  IL-2  receptor  expression;  then  IL-2, 
produced as a result of G7 binding, acts to stimulate proliferation. The induction 
of IL-2 receptors may require additional cytokines present in the heterogeneous 
cell culture. One practical use of G7  may be as an inducing agent to produce 
lymphokine-rich supernatants  from T  cell hybridomas and  tumors.  G7  could 
easily be removed by protein A affinity chromatography after the induction step. 
This procedure would be far superior to the use of agents such as mitogens or 
phorbol esters which are very difficult to remove from the lymphokine-containing 
supernatant. 
In  any  case,  the  ability  of the  G7  monoclonal  antibody  to  stimulate  IL-2 728  ANTI-THY-I-INDUCED T  CELL ACTIVATION 
receptor  expression,  IL-2  secretion,  and  T  cell  proliferation  is  similar  to  the 
responses of T  cells to antigens or mitogens. This suggests that the interaction 
of G7  with its epitope  initiates a  series of events common to T  cell activation 
mediated by multiple types of ligands. If this is true, then Thy-1 could be thought 
of as a transducing molecule intimately involved in T cell activation. For example, 
Thy-1  may be a  site for aggregation of T  cell  antigen  receptor  molecules or 
other  cell  surface  proteins  involved in  antigen  recognition.  Thus,  the  Thy-1 
molecule may represent  a  "final common pathway" by which T  cell activation 
mediated by any stimulus may proceed. 
Summary 
We  have  identified a  single  rat  monoclonai  antibody,  G7,  that  is  a  potent 
inducer of interleukin (IL-2) production from all functioning T  cell hybridomas 
as well as from normal T  cells. G7 is also mitogenic for normal T  cells and is a 
very effective inducer of IL-2  receptor  expression.  On  fluorescence-activated 
cell sorter analysis, G7  recognized a  pan-T  cell antigen.  Immunoprecipitation 
studies demonstrated that G7 recognized a  cell surface molecule of 28-32  kD 
that appeared to be identical to Thy-1 in coprecipitation studies. In addition, G7 
precipitated  a  protein  of  50  kD.  The  possible  relationship  of  the  putative 
molecular complex identified by G7 on murine cells to the molecular complex 
identified on human T  cells with anti-T3 reagents is discussed. In addition, G7 
should  prove  to  be  a  very  useful  reagent  for  studying  the  early  events  of 
lymphocyte activation as well as an inducer of lymphokine-rich supernatants. 
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